About: Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer
Creator	Douglas Letson, ; Greene, John Keenan, Robert Paculdo, David Peabody, John Spiess, Philippe
source	Medline; PMC
abstract	The alarming situation of the 2019 novel coronavirus disease (COVID‐19) is contrasted by the limited efforts to curb the spread and impact of the disease among patients with cancer. This commentary proposes a simple 5‐part strategy plus rapidly expanded use of telemedicine to anticipate and deal with COVID‐19 and, by extension, future epidemics in patients with cancer.
has issue date	2020-04-23(xsd:dateTime)
bibo:doi	10.1002/cncr.32919
bibo:pmid	32324273
has license	no-cc
sha1sum (hex)	ee74b11191d8028582951aa851e6565242661e4e
schema:url	https://doi.org/10.1002/cncr.32919
resource representing a document's title	Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer
has PubMed Central identifier	PMC7264676
has PubMed identifier	32324273
schema:publication	Cancer
resource representing a document's body	covid:ee74b11191d8028582951aa851e6565242661e4e#body_text
is schema:about of	named entity 'Coronavirus Disease' named entity 'US Department of Health and Human Services' named entity 'telemedicine' named entity 'clinical trials' named entity 'copays' named entity 'Medicare' named entity 'telemedicine' named entity 'diagnostic accuracy' named entity 'confidentiality' named entity 'costs of health care' named entity 'oncologists' named entity 'health care' named entity 'telemedicine' named entity 'telemedicine' named entity 'Moffitt Cancer Center' named entity 'Moffitt Cancer Center' named entity 'clinical practice' named entity 'telemedicine' named entity 'telemedicine' named entity 'University of California' named entity 'COVID' named entity 'telemedicine' named entity 'CHALLENGE' named entity 'CANCER' named entity 'Patients' named entity 'With' named entity 'Cancer' named entity 'Meeting' named entity 'Disease' named entity 'Novel' named entity 'Coronavirus' named entity '2019' named entity 'Challenge' named entity 'PATIENTS' named entity 'CORONAVIRUS DISEASE' named entity 'MEETING' named entity '2019 NOVEL CORONAVIRUS'
is part of of	covid:ee74b11191d8028582951aa851e6565242661e4e#body_text The alarming situation of the 2019 novel coronavirus disease (COVID‐19) is contrasted by the limited efforts to curb the spread and impact of the disease among patients with cancer. This commentary proposes a simple 5‐part strategy plus rapidly expanded use of telemedicine to anticipate and deal with COVID‐19 and, by extension, future epidemics in patients with cancer. Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software